Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Medication Overuse Prevalent Among US Migraine Patients

Key clinical point: Medication overuse is prevalent among U.S. migraine patients and significantly links with impaired function and disability.

Major finding: Medication overuse occurred in 18% of surveyed U.S. residents who met the study’s definition of having migraine.

Study details: Analysis of survey results from the CaMEO study, with 16,789 U.S. residents identified with migraine.

Disclosures: CaMEO was funded by Allergan. Dr. Schwedt has been a consultant to Allergan, and also to Alder, Amgen, Cipla, Dr. Reddy’s, Ipsen, Lilly, Novartis, and Teva; he had stock ownership in Aural Analytics, Nocira, and Second Opinion; and he has received research funding from Amgen.


Schwedt TJ et al. Headache. 2019 June;59[S1]:83-4, Abstract P92